InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: avav1001 post# 79

Thursday, 08/29/2019 1:03:06 PM

Thursday, August 29, 2019 1:03:06 PM

Post# of 376
The cells aren't matched as they use iPSCs in order to provide a renewable cell source for consistent and repeated manufacture of homogeneous cell products.

The company uses addition genetic engineering to try and reduced (or stop) rejection by the recipient's T and NK cells. They have shown already they can administer up to six treatments without any DLTs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News